Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort.

Subjects

Subjects :

Humans
Female
Male
Denmark epidemiology
Middle Aged
Incidence
Aged
Risk Factors
Adult
Aged, 80 and over
Cohort Studies
Treatment Outcome
Lymphoma, Follicular epidemiology
Lymphoma, Follicular drug therapy
Lymphoma, Follicular pathology
Rituximab therapeutic use
Disease Progression

Details

Language :

English

ISSN :

2044-5385

Volume :

14

Issue :

1

Database :

MEDLINE

Journal :

Blood cancer journal

Publication Type :

Report

Accession number :

39349431

Full Text :

https://doi.org/10.1038/s41408-024-01150-3